Carderock Capital Management Inc. Has $10.30 Million Stock Holdings in Lam Research Co. (NASDAQ:LRCX)

Carderock Capital Management Inc. raised its holdings in shares of Lam Research Co. (NASDAQ:LRCXFree Report) by 7.5% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 13,148 shares of the semiconductor company’s stock after purchasing an additional 919 shares during the period. Lam Research accounts for 2.8% of Carderock Capital Management Inc.’s portfolio, making the stock its 7th largest position. Carderock Capital Management Inc.’s holdings in Lam Research were worth $10,298,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Valued Wealth Advisors LLC bought a new position in Lam Research in the fourth quarter worth approximately $30,000. Bollard Group LLC raised its position in Lam Research by 60.0% in the second quarter. Bollard Group LLC now owns 40 shares of the semiconductor company’s stock worth $26,000 after acquiring an additional 15 shares during the period. Orion Capital Management LLC bought a new position in Lam Research in the third quarter worth approximately $25,000. BluePath Capital Management LLC bought a new stake in shares of Lam Research during the 3rd quarter valued at $28,000. Finally, Resurgent Financial Advisors LLC bought a new stake in shares of Lam Research during the 2nd quarter valued at $29,000. Institutional investors own 84.61% of the company’s stock.

Lam Research Trading Up 1.1 %

NASDAQ LRCX opened at $978.37 on Thursday. Lam Research Co. has a 12 month low of $480.45 and a 12 month high of $1,007.39. The company has a 50-day moving average of $919.82 and a 200-day moving average of $772.45. The company has a debt-to-equity ratio of 0.61, a current ratio of 3.06 and a quick ratio of 2.02. The company has a market cap of $128.26 billion, a P/E ratio of 37.83, a P/E/G ratio of 3.44 and a beta of 1.51.

Lam Research (NASDAQ:LRCXGet Free Report) last issued its earnings results on Wednesday, January 24th. The semiconductor company reported $7.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.06 by $0.46. Lam Research had a return on equity of 44.47% and a net margin of 24.15%. The business had revenue of $3.76 billion during the quarter, compared to analysts’ expectations of $3.71 billion. During the same quarter in the previous year, the business earned $10.71 EPS. The company’s revenue for the quarter was down 28.8% on a year-over-year basis. As a group, equities analysts predict that Lam Research Co. will post 28.88 earnings per share for the current year.

Lam Research Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, April 3rd. Stockholders of record on Wednesday, March 13th were given a dividend of $2.00 per share. This represents a $8.00 dividend on an annualized basis and a dividend yield of 0.82%. The ex-dividend date was Tuesday, March 12th. Lam Research’s payout ratio is currently 30.94%.

Insider Transactions at Lam Research

In other Lam Research news, SVP Seshasayee Varadarajan sold 5,500 shares of Lam Research stock in a transaction on Monday, March 18th. The shares were sold at an average price of $922.41, for a total value of $5,073,255.00. Following the completion of the transaction, the senior vice president now owns 22,095 shares of the company’s stock, valued at $20,380,648.95. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, SVP Seshasayee Varadarajan sold 5,500 shares of Lam Research stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $922.41, for a total transaction of $5,073,255.00. Following the sale, the senior vice president now directly owns 22,095 shares in the company, valued at $20,380,648.95. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Abhijit Y. Talwalkar sold 882 shares of Lam Research stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $972.03, for a total transaction of $857,330.46. Following the sale, the director now owns 10,541 shares in the company, valued at $10,246,168.23. The disclosure for this sale can be found here. Over the last quarter, insiders sold 7,029 shares of company stock valued at $6,559,489. 0.32% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several analysts have recently commented on the stock. Citigroup raised their price objective on shares of Lam Research from $800.00 to $975.00 and gave the company a “buy” rating in a research report on Thursday, January 25th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $900.00 price target on shares of Lam Research in a report on Monday, March 4th. TD Cowen lifted their price objective on shares of Lam Research from $710.00 to $975.00 and gave the stock an “outperform” rating in a research note on Thursday, January 25th. Stifel Nicolaus lifted their price objective on shares of Lam Research from $850.00 to $950.00 and gave the stock a “buy” rating in a research note on Thursday, January 25th. Finally, Needham & Company LLC lifted their price target on shares of Lam Research from $800.00 to $900.00 and gave the stock a “buy” rating in a research note on Thursday, January 25th. Eight equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat, Lam Research currently has a consensus rating of “Moderate Buy” and a consensus target price of $826.68.

Get Our Latest Report on LRCX

About Lam Research

(Free Report)

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Further Reading

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.